Skip to content
UKB - Strahlentherapie und Radioonklogie

Short Curriculum Vitae

Prof. Dr. Olga Golubnitschaja,

E-Mail: olga.golubnitschaja@ukbonn.de

Prof. Dr. Golubnitschaja, Head of the Research group 3P Medicine, Department of Radiation Oncology, University Hospital, Rheinische Friedrich-Wilhelms-University in Bonn, Germany, has studied journalism, biotechnology and medicine and has been awarded research fellowships in Austria, Russia, UK, Germany, Netherlands, and Switzerland (early and predictive diagnostics in
paediatrics, neurosciences and cancer). Dr. Golubnitschaja is the author of more than 400 international publications (research and review articles, position papers, books and book
contributions) in the innovative field of predictive, preventive and personalised medicine (3PM) with the main research focuses on predictive diagnostics in cancer, diabetes, cardiovascular
disease and neurodegenerative pathologies.

h-index 33; over 1.500 citations


Awards:

National & International Fellowship of the Alexander von Humboldt-Foundation;
Highest Prize in Medicine and Eiselsberg-Prize in Austria.

Since 2009 Dr. Golubnitschaja is the Secretary-General of the “European Association for Predictive, Preventive & Personalised Medicine” (EPMA, Brussels) networking about 60
countries worldwide, www.epmanet.eu, Editor-in-Chief of the EPMA J. (IF 4.661, Springer-Nature), Editor of the “European Journal of Gynaecological Oncology”, Book Series Editor of
“Advances in Predictive, Preventive & Personalised Medicine”, Springer Nature; Book Editor of “Predictive Diagnostics & Personalised Treatment: Dream or Reality”, Nova Science Publishers,
New York 2009; Book Co-editor of “Personalisierte Medizin”, Health Academy, Dresden 2010; Book Editor “Flammer Syndrome: From Phenotype to Associated Pathologies, Prediction, 2
Prevention and Personalisation”, Springer-Nature 2019 (International Award by EMA 2020);
Invited contributor to the Book “The Modern Hospital: Patient Centred, Disease Based, Research Oriented, Technology Driven” Springer Nature 2019.

Dr. Golubnitschaja is the European Representative in the EDR-Network at the National Institutes of Health USA, http://edrn.nci.nih.gov/.

Dr. Golubnitschaja is a regular reviewer for over 30 clinical and scientific journals and serves as a grant reviewer for the national (Ministries of Health in several European countries) and
international funding bodies. Since 2007 until the present, Dr. Golubnitschaja works as the European Commission evaluation expert for FP7, Horizon 2020, IMI-1 (Innovative Medical Initiatives) and IMI-2. In years 2010-2013 she was involved in creating the 3PM related contents of the European Programme “Horizon 2020”.

Currently, Dr. Golubnitschaja is Vice-Chair of the Evaluation Panel for Marie Curie Mobility Actions at the European Commission in Brussels.

Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Beauftragter.Medizinproduktesicherheit@ukbonn.de

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.